利空突袭！特朗普，发出威胁：动用一切手段！

Core Points - President Trump has demanded major pharmaceutical companies to take measures to lower drug prices in the U.S. within 60 days, threatening to use "all means" if they refuse [1][2] - The pharmaceutical industry has seen a significant drop in stock prices following Trump's announcement, with companies like Sanofi and Novo Nordisk experiencing declines of over 7% and nearly 6% respectively [1][6] - Trump has previously signed an executive order aimed at linking U.S. drug prices to lower prices in other countries, which he believes will help reduce costs [2][3] Industry Response - The pharmaceutical industry has long opposed the idea of linking global drug prices, arguing it threatens U.S. leadership in biomedical research and innovation [7] - Some companies have shown willingness to cooperate with the government, with AstraZeneca's CEO acknowledging the unsustainable nature of current pricing [7][8] - Major trade organizations in the pharmaceutical sector remain resistant to proposed reforms, emphasizing that foreign price controls could harm U.S. interests [7] Specific Measures Requested - Trump has outlined specific measures for pharmaceutical companies, including implementing "most favored nation" pricing, locking in new drug prices, pressuring foreign markets, and bypassing intermediaries to sell directly to consumers [5]